ELV - Elevance Health, Inc.

QQQ $ 475.77 $ -4.16 (-0.87 %)

DIA $ 412.95 $ 0.10 (0.03 %)

SPY $ 560.84 $ -2.35 (-0.42 %)

TLT $ 98.32 $ -0.33 (-0.33 %)

GLD $ 232.25 $ -1.23 (-0.53 %)

Previous Close

$ 545.96

Open

$ 546.17

Bid

$ 547.54 x 107

Ask

$ 547.82 x 100

Day's Range

$ 546.17 - $ 550.43

52 Week Range

$ 427.37 - $ 555.36

Volume

429,057

Average Volume

Market Cap

126.6B

Beta (5Y Monthly)

$ 1.01

PE Ratio (TTM)

$ 18.92

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-17-2024	06-30-2024	10-Q
2	04-18-2024	03-31-2024	10-Q
3	02-21-2024	12-31-2023	10-K
4	10-18-2023	09-30-2023	10-Q
5	07-19-2023	06-30-2023	10-Q
6	04-19-2023	03-31-2023	10-Q
7	02-15-2023	12-31-2022	10-K
8	10-19-2022	09-30-2022	10-Q
9	07-20-2022	06-30-2022	10-Q
10	04-20-2022	03-31-2022	10-Q
11	02-16-2022	12-31-2021	10-K
12	10-20-2021	09-30-2021	10-Q
13	07-21-2021	06-30-2021	10-Q
14	04-21-2021	03-31-2021	10-Q
15	02-18-2021	12-31-2020	10-K
16	10-28-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	04-29-2020	03-31-2020	10-Q
19	02-19-2020	12-31-2019	10-K
20	10-23-2019	09-30-2019	10-Q
21	07-24-2019	06-30-2019	10-Q
22	04-24-2019	03-31-2019	10-Q
23	02-20-2019	12-31-2018	10-K
24	10-31-2018	09-30-2018	10-Q
25	07-25-2018	06-30-2018	10-Q
26	04-25-2018	03-31-2018	10-Q
27	02-21-2018	12-31-2017	10-K
28	10-25-2017	09-30-2017	10-Q
29	07-26-2017	06-30-2017	10-Q
30	04-26-2017	03-31-2017	10-Q
31	02-22-2017	12-31-2016	10-K
32	11-02-2016	09-30-2016	10-Q
33	07-27-2016	06-30-2016	10-Q
34	04-27-2016	03-31-2016	10-Q
35	02-19-2016	12-31-2015	10-K
36	10-28-2015	09-30-2015	10-Q
37	07-29-2015	06-30-2015	10-Q
38	04-29-2015	03-31-2015	10-Q
39	02-24-2015	12-31-2014	10-K
40	10-29-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms

Evolent Health Explores Sale, Garners Inbo...
08/23/2024 14:32:15

Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.

heres-how-much-1000-invested-in-elevance-health-10-years-ago-would-be-worth-today

Here's How Much $1000 Invested In Elevance...
08/22/2024 20:31:05

Evolent Health Explores Sale Following Acq...
08/22/2024 17:18:19

- Reuters Citing Sources

looking-at-elevance-healths-recent-unusual-options-activity

Looking At Elevance Health's Recent Unusua...
08/20/2024 19:16:20

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
08/19/2024 17:35:23

What Analysts Are Saying About Elevance He...
08/19/2024 16:00:40

Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 15:26:32

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

an-irrelevant-company-jim-cramer-says-snap-is-not-investable

'An Irrelevant Company': Jim Cramer Says S...
08/13/2024 12:50:01

Jim Cramer suggests buying Applied Materials despite government concerns, Aflac not favored, UnitedHealth Group best, Snap not ...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

1000-invested-in-this-stock-20-years-ago-would-be-worth-13000-today

$1000 Invested In This Stock 20 Years Ago ...
08/07/2024 20:30:18

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-10000-today

If You Invested $1000 In This Stock 15 Yea...
07/25/2024 18:00:21

how-is-the-market-feeling-about-elevance-health

How Is The Market Feeling About Elevance H...
07/23/2024 18:00:20

Cantor Fitzgerald Reiterates Overweight on...
07/23/2024 16:07:24

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

Wells Fargo Maintains Overweight on Elevan...
07/22/2024 13:48:58

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $...

TD Cowen Maintains Buy on Elevance Health,...
07/19/2024 16:42:03

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.

bofa-downgrades-elevance-health-on-medicaid-pressure-and-lowered-peer-valuations

BofA Downgrades Elevance Health On Medicai...
07/18/2024 18:50:28

Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid me...

a-closer-look-at-elevance-healths-options-market-dynamics

A Closer Look at Elevance Health's Options...
07/18/2024 17:01:46

Barclays Maintains Overweight on Elevance ...
07/18/2024 15:25:59

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $621 to ...

RBC Capital Maintains Outperform on Elevan...
07/18/2024 14:12:20

RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $575...

B of A Securities Downgrades Elevance Heal...
07/18/2024 11:09:29

B of A Securities analyst Kevin Fischbeck downgrades Elevance Health (NYSE:ELV) from Buy to Neutral and lowers the price tar...